NEW YORK – Royalty Pharma plc said on Tuesday it acquired a royalty interest in two of Nuvalent Inc’s experimental lung cancer therapies for up to $315 million, betting on the drugs’ multi-billion dollar sales potential. The deal gives the royalty investment firm a low-single-digit percentage of worldwide net sales for neladalkib and zidesamtinib, next-generation…
GAITHERSBURG – AstraZeneca said on Monday it will invest $2 billion to expand its manufacturing footprint in Maryland, including a major expansion of its biologics facility in Frederick and construction of a new clinical manufacturing site in Gaithersburg. The investment will support 2,600 jobs across the two sites, including 300 highly skilled roles, retention of…
AMSTERDAM – Life sciences company QIAGEN NV said on Monday it has agreed to acquire Parse Biosciences, a provider of single-cell sequencing solutions, for an upfront $225 million in cash, aiming to capture a larger share of the fast-growing market for analyzing individual cells. The deal for the privately held U.S.-based company includes the potential…
LONDON: Partners Group Private Equity Limited (PGPE Ltd) announced Monday the sale of Clario, a leading provider of clinical trial data solutions, to Thermo Fisher Scientific. The transaction, subject to customary regulatory approvals, is expected to close by the end of the second quarter of 2026. Clario, headquartered in Philadelphia, is PGPE Ltd’s eighth-largest portfolio…
LONDON: Diaceutics PLC (AIM: DXRX), a technology provider for pharmaceutical and biotech companies, announced strong first-half revenue growth driven by increased demand for its precision medicine commercialization services. Revenue rose 22% on a constant currency basis to £14.6 million ($18.9 million) in H1 2025, marking a three-year compound annual growth rate of 25%. Recurring revenue…
NEW YORK: Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging, announced Tuesday the execution of a definitive agreement to merge with True Health Inc., operator of the THPlasma brand, in an all-stock transaction. The combined company is expected to continue trading on Nasdaq under the ticker “XAGE” after…
LONDON: Eden Research plc, a sustainable biopesticide and biocontrol technology company, announced a strategic partnership with Royal Holloway, University of London, to advance its seed treatment product for cereals and vegetables. The collaboration, formed under Innovate UK’s Knowledge Transfer Partnership program, will leverage academic expertise and research facilities to broaden the application of Eden’s flagship…
LONDON: N4 Pharma plc (AIM: N4P), a UK-based biotechnology company developing its proprietary Nuvec® gene delivery system for advanced cancer and disease therapies, announced its audited financial results for the year ended Dec. 31, 2024. The company’s annual report and notice of its annual general meeting (AGM) have been distributed to shareholders. The AGM will…
Swiss oncology biotech firm Araris Biotech AG has entered into an acquisition agreement with Taiho Pharmaceutical Co., Ltd, marking a significant milestone for the advanced therapies industry, 4BIO Capital announced Monday. The Japanese company will pay $400 million upfront, with additional milestone payments potentially bringing the total to $1.14 billion. The acquisition is set to close in…
LONDON: BSF, a biotech company that owns tissue engineering firms 3DBT and Kerato, has signed a memorandum of understanding with Maison Amelie Pichard, a fashion company that uses eco-friendly materials, to develop and sell fashion accessories that incorporate lab-grown leather. This is the first time that real lab-grown leather, which mimics the structure of traditional…
WELLINGTON, NEW ZEALAND: KiwiSaver provider, Booster Investment Management Limited, is kicking off the first NZX listing of 2022, with the launch of its new retail investment fund, the Booster Innovation Fund (BIF). The investment fund is the very first of its kind listed on the NZX (on 2 March), providing Kiwis with direct access to…
Abcam Plc is a producer, distributor and seller of protein research tools. The company was founded in 1998 by Jonathan Milner with co-founders professor Tony Kouzarides and David Cleevely, with the idea of making it easier for research scientists to buy antibodies across the web. Milner was a postdoctoral researcher studying the newly discovered breast…